Literature DB >> 19496487

Fiber types, asbestos potency, and environmental causation: a peer review of published work and legal and regulatory scientific testimony.

David Egilman1.   

Abstract

Scientific evidence and analysis offered in litigation and public policy testimony have an important role in occupational and environmental health, but are not subject to peer review. Critique and commentary, attempts at reproduction of results, and review of data offered in such testimony is essential. Peer review of such testimony should become part of the domain of medical and scientific journals. This paper is an effort to peer review the use of certain scientific methods in tort litigation and in testimony before regulatory agencies. In this issue of IJOEH, Azuma et al. show that background asbestos exposures can be considered to have caused mesothelioma. In contrast, epidemiologic studies and testimony by Teta et al. and Price and Ware, and pathologic studies and testimony by Roggli and others, claim that background exposures are benign. These are fatally flawed because of methodological and analytic errors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19496487     DOI: 10.1179/oeh.2009.15.2.202

Source DB:  PubMed          Journal:  Int J Occup Environ Health        ISSN: 1077-3525


  4 in total

Review 1.  When the Diagnosis of Mesothelioma Challenges Textbooks and Guidelines.

Authors:  Giulio Rossi; Fabio Davoli; Venerino Poletti; Alberto Cavazza; Filippo Lococo
Journal:  J Clin Med       Date:  2021-05-30       Impact factor: 4.241

2.  Comments on the 2014 Helsinki consensus report on asbestos.

Authors: 
Journal:  Ind Health       Date:  2016       Impact factor: 2.179

3.  Comments on the 2014 helsinki consensus report on asbestos.

Authors:  Collegium Ramazzini
Journal:  J Occup Health       Date:  2016-03-31       Impact factor: 2.708

4.  Ongoing downplaying of the carcinogenicity of chrysotile asbestos by vested interests.

Authors:  Xaver Baur; Arthur L Frank
Journal:  J Occup Med Toxicol       Date:  2021-02-23       Impact factor: 2.646

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.